Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Therapies in Combination or Sequentially With Tyrosine Kinase Inhibitors (TKIs) in Chronic Phase Chronic Myelogenous Leukemia Patients in CCR (ACTIW)Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase, Myeloproliferative Disorders, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bone marrow disorder, hematologic disorder, leukemia, myeloid leukemia, neoplasmActive, not recruitingPhase 1 / Phase 22026-09-28NCT02767063

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Versailles Hospital20

23 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
CayssialsPoitiersFrance1
CH Henri MondorCréteilFrance1
CHU Côte de NacreCaenFrance4
CHU de LimogesLimogesFrance30
CHU de Rennes - PontchaillouRennesFrance1
Chu EstaingClermont-FerrandFrance18
CHU LilleLilleFrance63
CHU ToursToursFrance36
Delphine REA _St louisParisFrance1
Eric JOURDANNîmesFrance1
EtienneBordeauxFrance1
Franck NICOLINILyonFrance1
Hopital l'ArchetNiceFrance1
Hôpital La SourceOrléansFrance1
Hôpital René HugueninSaint-CloudFrance3
Institut P CalmetteMarseilleFrance1
Institut Universitaire contre le CancerToulouseFrance1
Martine GARDEMBASAngersFrance1
Pascale CONY.MAKHOULAnnecyFrance1
RousselotLe ChesnayFrance1
Simona LAPUSAN_St AntoineParisFrance1
Thorsten BRAUNBobignyFrance1
Viviane DUBRUILLENantesFrance1